Medical management: Its accomplishments in Crohn's disease and indications for surgery

  title={Medical management: Its accomplishments in Crohn's disease and indications for surgery},
  author={Robert N. Allan},
  journal={World Journal of Surgery},
  • R. Allan
  • Published 1 April 1988
  • Medicine
  • World Journal of Surgery
AbstractWhile the etiology of Crohn's disease remains unknown, the optimal treatment of patients with this complaint must include integrated medical and surgical management.Crohn's disease is, in practice, not a single disorder but comprises a wide variety of disorders masquerading under the one name, so that each patient requires careful individual evaluation, including a review of previous resections and a clear definition of the site and extent of macroscopic disease. Any anemia and fluid or… Expand
1 Citations
Immunosuppressive Drugs: Do they have Any Role in the Treatment of IBD?
The immune system seems to be involved in the pathogenesis of IBD although the mechanisms are unknown. Certainly the immune system shows evidence of activation during exacerbations of disease. BasedExpand


Crohn's disease involving the colon: an audit of clinical management.
Until the etiology of Crohn's disease is established and a specific therapy is developed, good results can be obtained with regular medical review and appropriate surgical treatment with the limited use of immunosuppressive agents or total parenteral nutrition. Expand
Crohn's disease in the elderly.
The natural history of Crohn's disease in 47 patients, 60 years of age or older at the time of diagnosis has been defined, and their clinical management and long term prognosis reviewed. DistalExpand
Parenteral nutrition in Crohn's disease
A retrospective study of 50 consecutive patients admitted to hospital with Crohn's disease has been undertaken, finding that parenteral nutrition, if required, is usually only necessary for periods of less than two weeks, to support patients over a critical period in their illness. Expand
Elemental diet as primary treatment of acute Crohn's disease: a controlled trial.
Assessment at four and 12 weeks showed that the patients treated with the elemental diet had improved as much as and by some criteria more than the steroid treated group. Expand
Total parenteral nutrition as primary therapy for inflammatory disease of the bowel
Of the five patients with mucosal ulcerative colitis who were treated with primary TPN, three are now doing well in response to medical therapy after a mean follow-up period of 27.3 months. Expand
Crohn's disease of the distal ileum.
The long-term prognosis, cumulative reoperation rates after each resection, mortality rates, and their causes were determined, and there was a two-fold increase in mortality risk when compared with the general population. Expand
Elemental diets in treatment of acute Crohn's disease.
Twenty-seven patients with 32 acute exacerbations of Crohn's disease were treated for four weeks with an elemental diet, and 29 of the exacerbations had remitted both clinically and biochemically. Expand
Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis.
The results of this trial show that IVH with total bowel rest has no primary therapeutic effect in acute colitis. Expand
Controlled trial of rifampicin and ethambutol in Crohn's disease.
There was no consistent pattern of change in prednisolone requirements although eight patients on long term sulphasalazine had a significant reduction in their plasma sulphapyridine concentrations during the active treatment period. Expand
A trial of sulfasalazine as adjunctive therapy in Crohn's disease.
Sulfasalazine showed no prednisone-sparing effect as judged either by outcome ranking or total dose ofprednisone consumed by the two treatment groups, however, in this comparison the probability is greater than 5% that, given the results observed, a clinically useful effect of sulf asalazine of specified minimum degree truly exists. Expand